252 related articles for article (PubMed ID: 26329348)
1. Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis.
Qi Q; Wang R; Liu L; Zhao F; Wang S
Int J Clin Pharmacol Ther; 2015 Oct; 53(10):803-10. PubMed ID: 26329348
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP; Wu TS; Dan YY
J Clin Pharm Ther; 2015 Aug; 40(4):368-75. PubMed ID: 25893507
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of esomeprazole and omeprazole: Racemate to single enantiomer switch.
Asghar W; Pittman E; Jamali F
Daru; 2015 Nov; 23():50. PubMed ID: 26573220
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effectiveness of esomeprazole treatment strategies in the management of patients with gastroesophageal reflux disease symptoms: a meta-analysis.
Mei J; Yu Y; Ma J; Yu X
Pharmazie; 2016 May; 71(5):285-91. PubMed ID: 27348974
[TBL] [Abstract][Full Text] [Related]
5. Esomeprazole: a review of its use in the management of acid-related disorders.
Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
Drugs; 2002; 62(10):1503-38. PubMed ID: 12093317
[TBL] [Abstract][Full Text] [Related]
6. Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease.
Wu MS; Tan SC; Xiong T
Aliment Pharmacol Ther; 2013 Jul; 38(2):190-201. PubMed ID: 23718547
[TBL] [Abstract][Full Text] [Related]
7. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
Moraes-Filho JP; Pedroso M; Quigley EM;
Aliment Pharmacol Ther; 2014 Jan; 39(1):47-56. PubMed ID: 24299323
[TBL] [Abstract][Full Text] [Related]
8. Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs.
Edwards SJ; Lind T; Lundell L
Aliment Pharmacol Ther; 2006 Sep; 24(5):743-50. PubMed ID: 16918878
[TBL] [Abstract][Full Text] [Related]
9. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
Hatlebakk JG; Zerbib F; Bruley des Varannes S; Attwood SE; Ell C; Fiocca R; Galmiche JP; Eklund S; Långström G; Lind T; Lundell LR;
Clin Gastroenterol Hepatol; 2016 May; 14(5):678-85.e3. PubMed ID: 26226096
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.
Attwood SE; Ell C; Galmiche JP; Fiocca R; Hatlebakk JG; Hasselgren B; Långström G; Jahreskog M; Eklund S; Lind T; Lundell L
Aliment Pharmacol Ther; 2015 Jun; 41(11):1162-74. PubMed ID: 25858519
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies.
Wahlqvist P; Junghard O; Higgins A; Green J
Pharmacoeconomics; 2002; 20(4):267-77. PubMed ID: 11950383
[TBL] [Abstract][Full Text] [Related]
13. Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study.
Hoogendoorn RJ; Groeneveld L; Kwee JA
Clin Drug Investig; 2009; 29(12):803-10. PubMed ID: 19888786
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.
Sakurai K; Suda H; Fujie S; Takeichi T; Okuda A; Murao T; Hasuda K; Hirano M; Ito K; Tsuruta K; Hattori M
Dig Dis Sci; 2019 Mar; 64(3):815-822. PubMed ID: 30415407
[TBL] [Abstract][Full Text] [Related]
15. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
Jonasson C; Tvete IF; Hatlebakk JG
Scand J Gastroenterol; 2013 Sep; 48(9):1010-7. PubMed ID: 23859491
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis.
Edwards SJ; Lind T; Lundell L
Aliment Pharmacol Ther; 2001 Nov; 15(11):1729-36. PubMed ID: 11683686
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
[TBL] [Abstract][Full Text] [Related]
18. [Pharma clinics medication of the month. Esomeprazole].
Louis E
Rev Med Liege; 2002 Sep; 57(9):610-2. PubMed ID: 12440351
[TBL] [Abstract][Full Text] [Related]
19. [Use of omeprazole and esomeprazole in patients suffering from bronchial asthma with associated gastroesophageal reflux disease].
Maev IV; Viuchnova ES; Balashova NN; Shchekina MI
Eksp Klin Gastroenterol; 2003; (3):26-31, 116. PubMed ID: 14556543
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
